Strategic Expansion Creates Future Optionality In addition to advancing its core GLP-1 metabolic disease platform, SureNano Science is also evaluating early-stage opportunities that could broaden the long-term scope of its therapeutic and delivery technology portfolio
If you've been following the weight loss medication space Ozempic, Wegovy, Mounjaro, Zepbound you've probably noticed a new name popping up: retatrutide
Instead, it gently turns down the food noisea phrase thats used frequently to describe the effects of GLP-1sto make it easier to establish new habits
Metabolic Rate of Different Tissues Wang Z et al
The team of Ralf Jockers in collaboration with the team of Dr Amlie Bonnefond from the European Genomic Institute for Diabetes (EGID, Lille, France), the Huazhong University of Science and Technology (Wuhan, China), the Baylor College of Medicine (Houston, USA) and Imperial College Lonodon (UK) performed a large-scale functional genetics analysis of 60 rare GLP1R mutations
Weeks 1 through 4: the adjustment phase Gastrointestinal side effects peak during the first month and with each subsequent dose increase
